Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients

Fabrizio Fabrizi, Paul Martin, Vivek Dixit, Maria Brezina, James Russell, Andy Conrad, Peter Schmid, Silvia Gerosa, Gary Gitnick

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Patients on chronic hemodialysis (HD) treatment have been identified by serological testing, including second- and third-generation enzyme-linked immunosorbent assay (ELISA), as a high-risk group for hepatitis C virus (HCV) infection. Previous studies have shown that de novo cases of HCV may occur in HD units in the absence of other parenteral exposures, which suggests the spread of HCV between patients. In addition, the reverse-transcription polymerase chain reaction (RT-PCR), which directly detects HCV virus, has identified HCV infection in chronic HD patients who are seronegative. The aim of this study was to determine the incidence of HCV infection detected by RT-PCR technology in a large cohort of chronic HD patients. One hundred and twenty chronic HD patients, HCV-negative by serological assays (second-generation ELISA) and molecular techniques (branched DNA and RT-PCR), were observed for a mean period of 9.5 months. They were tested monthly for serum alanine aminotransferase levels (ALT) and by second-generation ELISA. At the end of the follow-up period, they were again evaluated by branched DNA and RT-PCR testing. HCV RNA was detected in patients' sera by RT followed by PCR using two separate primer sets from the 5'-untranslated region of the HCV genome. Southern blot was performed using a digoxigenin-labeled probe. Two patients who had HCV RNA detectable by RT-PCR at the end of the follow-up period remained branched-DNA-negative. Thus, the incidence of de novo acquisition of HCV infection in the current investigation was 2.1% per year. In 1 patient RT-PCR positivity and anti-HCV ELISA seroconversion occurred. The 2nd patient remained anti-HCV ELISA-negative, although viremic. In both patients, the onset of positivity by RT-PCR was associated with a rise of ALT levels into the 'abnormal range' in our laboratory. In these 2 patients, de novo acquisition of HCV infection was observed in the absence of obvious parenteral risk factors other than their presence in the HD environment. In conclusion, de novo acquisition of HCV infection may be undetected by ELISA and branched-DNA assays. The need to monitor chronic HD patients by serial ALT testing is emphasized. RT-PCR shoud be incorporated into diagnostic testing for HCV infection in chronic HD patients. RT-PCR technology can identify HCV in HD individuals with raised ALT activity.

Original languageEnglish
Pages (from-to)383-388
Number of pages6
JournalAmerican Journal of Nephrology
Volume19
Issue number3
DOIs
StatePublished - May 1 1999
Externally publishedYes

Fingerprint

Virus Diseases
Hepacivirus
Renal Dialysis
Polymerase Chain Reaction
Reverse Transcription
Enzyme-Linked Immunosorbent Assay
DNA
Branched DNA Signal Amplification Assay
RNA
Technology
Digoxigenin
5' Untranslated Regions
Incidence
Southern Blotting
Serum
Alanine Transaminase

Keywords

  • Alanine aminotransferase
  • Hemodialysis
  • Hepatitis C viremia
  • Hepatitis C virus incidence
  • Reverse-transcriptase polymerase chain reaction

ASJC Scopus subject areas

  • Nephrology

Cite this

Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. / Fabrizi, Fabrizio; Martin, Paul; Dixit, Vivek; Brezina, Maria; Russell, James; Conrad, Andy; Schmid, Peter; Gerosa, Silvia; Gitnick, Gary.

In: American Journal of Nephrology, Vol. 19, No. 3, 01.05.1999, p. 383-388.

Research output: Contribution to journalArticle

Fabrizi, F, Martin, P, Dixit, V, Brezina, M, Russell, J, Conrad, A, Schmid, P, Gerosa, S & Gitnick, G 1999, 'Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients', American Journal of Nephrology, vol. 19, no. 3, pp. 383-388. https://doi.org/10.1159/000013482
Fabrizi, Fabrizio ; Martin, Paul ; Dixit, Vivek ; Brezina, Maria ; Russell, James ; Conrad, Andy ; Schmid, Peter ; Gerosa, Silvia ; Gitnick, Gary. / Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. In: American Journal of Nephrology. 1999 ; Vol. 19, No. 3. pp. 383-388.
@article{ac23dd40d0a74309ad86e54dc1c13a5f,
title = "Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients",
abstract = "Patients on chronic hemodialysis (HD) treatment have been identified by serological testing, including second- and third-generation enzyme-linked immunosorbent assay (ELISA), as a high-risk group for hepatitis C virus (HCV) infection. Previous studies have shown that de novo cases of HCV may occur in HD units in the absence of other parenteral exposures, which suggests the spread of HCV between patients. In addition, the reverse-transcription polymerase chain reaction (RT-PCR), which directly detects HCV virus, has identified HCV infection in chronic HD patients who are seronegative. The aim of this study was to determine the incidence of HCV infection detected by RT-PCR technology in a large cohort of chronic HD patients. One hundred and twenty chronic HD patients, HCV-negative by serological assays (second-generation ELISA) and molecular techniques (branched DNA and RT-PCR), were observed for a mean period of 9.5 months. They were tested monthly for serum alanine aminotransferase levels (ALT) and by second-generation ELISA. At the end of the follow-up period, they were again evaluated by branched DNA and RT-PCR testing. HCV RNA was detected in patients' sera by RT followed by PCR using two separate primer sets from the 5'-untranslated region of the HCV genome. Southern blot was performed using a digoxigenin-labeled probe. Two patients who had HCV RNA detectable by RT-PCR at the end of the follow-up period remained branched-DNA-negative. Thus, the incidence of de novo acquisition of HCV infection in the current investigation was 2.1{\%} per year. In 1 patient RT-PCR positivity and anti-HCV ELISA seroconversion occurred. The 2nd patient remained anti-HCV ELISA-negative, although viremic. In both patients, the onset of positivity by RT-PCR was associated with a rise of ALT levels into the 'abnormal range' in our laboratory. In these 2 patients, de novo acquisition of HCV infection was observed in the absence of obvious parenteral risk factors other than their presence in the HD environment. In conclusion, de novo acquisition of HCV infection may be undetected by ELISA and branched-DNA assays. The need to monitor chronic HD patients by serial ALT testing is emphasized. RT-PCR shoud be incorporated into diagnostic testing for HCV infection in chronic HD patients. RT-PCR technology can identify HCV in HD individuals with raised ALT activity.",
keywords = "Alanine aminotransferase, Hemodialysis, Hepatitis C viremia, Hepatitis C virus incidence, Reverse-transcriptase polymerase chain reaction",
author = "Fabrizio Fabrizi and Paul Martin and Vivek Dixit and Maria Brezina and James Russell and Andy Conrad and Peter Schmid and Silvia Gerosa and Gary Gitnick",
year = "1999",
month = "5",
day = "1",
doi = "10.1159/000013482",
language = "English",
volume = "19",
pages = "383--388",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients

AU - Fabrizi, Fabrizio

AU - Martin, Paul

AU - Dixit, Vivek

AU - Brezina, Maria

AU - Russell, James

AU - Conrad, Andy

AU - Schmid, Peter

AU - Gerosa, Silvia

AU - Gitnick, Gary

PY - 1999/5/1

Y1 - 1999/5/1

N2 - Patients on chronic hemodialysis (HD) treatment have been identified by serological testing, including second- and third-generation enzyme-linked immunosorbent assay (ELISA), as a high-risk group for hepatitis C virus (HCV) infection. Previous studies have shown that de novo cases of HCV may occur in HD units in the absence of other parenteral exposures, which suggests the spread of HCV between patients. In addition, the reverse-transcription polymerase chain reaction (RT-PCR), which directly detects HCV virus, has identified HCV infection in chronic HD patients who are seronegative. The aim of this study was to determine the incidence of HCV infection detected by RT-PCR technology in a large cohort of chronic HD patients. One hundred and twenty chronic HD patients, HCV-negative by serological assays (second-generation ELISA) and molecular techniques (branched DNA and RT-PCR), were observed for a mean period of 9.5 months. They were tested monthly for serum alanine aminotransferase levels (ALT) and by second-generation ELISA. At the end of the follow-up period, they were again evaluated by branched DNA and RT-PCR testing. HCV RNA was detected in patients' sera by RT followed by PCR using two separate primer sets from the 5'-untranslated region of the HCV genome. Southern blot was performed using a digoxigenin-labeled probe. Two patients who had HCV RNA detectable by RT-PCR at the end of the follow-up period remained branched-DNA-negative. Thus, the incidence of de novo acquisition of HCV infection in the current investigation was 2.1% per year. In 1 patient RT-PCR positivity and anti-HCV ELISA seroconversion occurred. The 2nd patient remained anti-HCV ELISA-negative, although viremic. In both patients, the onset of positivity by RT-PCR was associated with a rise of ALT levels into the 'abnormal range' in our laboratory. In these 2 patients, de novo acquisition of HCV infection was observed in the absence of obvious parenteral risk factors other than their presence in the HD environment. In conclusion, de novo acquisition of HCV infection may be undetected by ELISA and branched-DNA assays. The need to monitor chronic HD patients by serial ALT testing is emphasized. RT-PCR shoud be incorporated into diagnostic testing for HCV infection in chronic HD patients. RT-PCR technology can identify HCV in HD individuals with raised ALT activity.

AB - Patients on chronic hemodialysis (HD) treatment have been identified by serological testing, including second- and third-generation enzyme-linked immunosorbent assay (ELISA), as a high-risk group for hepatitis C virus (HCV) infection. Previous studies have shown that de novo cases of HCV may occur in HD units in the absence of other parenteral exposures, which suggests the spread of HCV between patients. In addition, the reverse-transcription polymerase chain reaction (RT-PCR), which directly detects HCV virus, has identified HCV infection in chronic HD patients who are seronegative. The aim of this study was to determine the incidence of HCV infection detected by RT-PCR technology in a large cohort of chronic HD patients. One hundred and twenty chronic HD patients, HCV-negative by serological assays (second-generation ELISA) and molecular techniques (branched DNA and RT-PCR), were observed for a mean period of 9.5 months. They were tested monthly for serum alanine aminotransferase levels (ALT) and by second-generation ELISA. At the end of the follow-up period, they were again evaluated by branched DNA and RT-PCR testing. HCV RNA was detected in patients' sera by RT followed by PCR using two separate primer sets from the 5'-untranslated region of the HCV genome. Southern blot was performed using a digoxigenin-labeled probe. Two patients who had HCV RNA detectable by RT-PCR at the end of the follow-up period remained branched-DNA-negative. Thus, the incidence of de novo acquisition of HCV infection in the current investigation was 2.1% per year. In 1 patient RT-PCR positivity and anti-HCV ELISA seroconversion occurred. The 2nd patient remained anti-HCV ELISA-negative, although viremic. In both patients, the onset of positivity by RT-PCR was associated with a rise of ALT levels into the 'abnormal range' in our laboratory. In these 2 patients, de novo acquisition of HCV infection was observed in the absence of obvious parenteral risk factors other than their presence in the HD environment. In conclusion, de novo acquisition of HCV infection may be undetected by ELISA and branched-DNA assays. The need to monitor chronic HD patients by serial ALT testing is emphasized. RT-PCR shoud be incorporated into diagnostic testing for HCV infection in chronic HD patients. RT-PCR technology can identify HCV in HD individuals with raised ALT activity.

KW - Alanine aminotransferase

KW - Hemodialysis

KW - Hepatitis C viremia

KW - Hepatitis C virus incidence

KW - Reverse-transcriptase polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0033063578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033063578&partnerID=8YFLogxK

U2 - 10.1159/000013482

DO - 10.1159/000013482

M3 - Article

C2 - 10393375

AN - SCOPUS:0033063578

VL - 19

SP - 383

EP - 388

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 3

ER -